Date Filed | Type | Description |
08/17/2023 |
4
| Klausner Richard (Director) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns:
| Sold 58,020 shares
@ $2.28, valued at
$132.3k
|
|
08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
09/27/2022 |
4
| Klausner Richard (Director) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns:
| Sold 11,100 shares
@ $6.4001, valued at
$71k
|
|
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/07/2018 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Gifted 23,250 shares
@ $0 Unknown transaction of 705,525 shares
@ $87, valued at
$61.4M
Disposed/sold 12,000 options to buy
@ $60, valued at
$720k
Disposed/sold 12,000 options to buy
@ $42.4, valued at
$508.8k
Disposed/sold 12,000 options to buy
@ $23.29, valued at
$279.5k
|
|
01/09/2018 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Granted 248 shares
@ $0 Sold 1,949 shares
@ $46.8495, valued at
$91.3k
Sold 5,011 shares
@ $47.8024, valued at
$239.5k
Sold 4,846 shares
@ $48.9523, valued at
$237.2k
Sold 918 shares
@ $49.3696, valued at
$45.3k
|
|
12/22/2017 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Sold 32,859 shares
@ $44.7216, valued at
$1.5M
Sold 3,141 shares
@ $45.1605, valued at
$141.8k
|
|
10/06/2017 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Granted 266 shares
@ $0 |
|
09/08/2017 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Sold 5,449 shares
@ $42.2685, valued at
$230.3k
Sold 5,214 shares
@ $42.7579, valued at
$222.9k
Sold 1,337 shares
@ $43.833, valued at
$58.6k
|
|
08/09/2017 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Sold 12,000 shares
@ $30.3409, valued at
$364.1k
|
|
07/07/2017 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Granted 380 shares
@ $0 Sold 23,600 shares
@ $29.378, valued at
$693.3k
Sold 400 shares
@ $29.9975, valued at
$12k
|
|
06/19/2017 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Granted 12,000 options to buy
@ $23.29, valued at
$279.5k
|
|
06/09/2017 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Sold 15,232 shares
@ $23.2296, valued at
$353.8k
Sold 8,768 shares
@ $24.2391, valued at
$212.5k
|
|
04/06/2017 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc. |
01/09/2017 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc. |
10/17/2016 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc. |
07/05/2016 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Granted 300 shares
@ $0 |
|
06/24/2016 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Sold 12,000 shares
@ $40.708, valued at
$488.5k
|
|
06/21/2016 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Granted 12,000 options to buy
@ $42.4, valued at
$508.8k
|
|
05/20/2016 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Sold 12,000 shares
@ $40, valued at
$480k
|
|
04/19/2016 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Sold 10,007 shares
@ $42.7851, valued at
$428.2k
Sold 1,993 shares
@ $43.5056, valued at
$86.7k
|
|
04/07/2016 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Granted 300 shares
@ $0 |
|
03/22/2016 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Sold 12,000 shares
@ $40, valued at
$480k
|
|
03/02/2016 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns:
| Sold 23,240 shares
@ $40.3914, valued at
$938.7k
Sold 760 shares
@ $41.2196, valued at
$31.3k
|
|
02/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|